TEHRAN, Iran, May 25. Iranian government's policy of ending the allocation of subsidized foreign currency (42,000 rials per dollar) to pharmaceutical imports is a mistake, member of parliament health and medical commission Malek Fazeli told Trend.
"The reduction of spending for pharmaceutical import would result in life threats and casualties," he said.
Fazeli pointed out that ending subsidies for pharmaceutical imports would reduce the quality of domestic pharmaceutical products and patients lose access to vital medicines leading to soaring prices.
According to the MP, the following policy will lead increase costs of pharmaceutical production and scarcity of medicines.
The Iranian government policy is to cut large subsidies as part of its subsidy reform plan.